Resolution of an online meeting of the Siberian, Far Eastern and Southern Federal Districts experts on the results of the EMPEROR-Reduced trial “Therapeutic approaches in heart failure with reduced ejection fraction: the EMPA-REG OUTCOME trial and the EMPEROR-Reduced trial”
O. L. Barbarash,
V. V. Kashtalap,
A. A. Garganeeva,
K. V. Protasov,
O. Yu. Korennova,
N. G. Gogolashvili,
A. S. Salasyuk,
A. A. Efremushkina,
S. L. Zharskiy,
S. A. Zenin,
S. А. Makarov,
V. A. Nevzorova,
L. B. Sodnomova,
S. A. Ustyugov,
O. G. Tsygankova,
Yu. O. Shabelnikova https://doi.org/10.17802/2306-1278-2021-10-3-121-129
Abstract
At the online meeting of experts held on April 24, 2021, the results of the international multicenter trial EMPEROR-Reduced were considered. Taking into account the beneficial cardiovascular and renal outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction (<40%), and improvement in patient survival rates, a number of proposals and recommendations for widespread implementation of the trial results into practice of treating patients with chronic heart failure were adopted.
About the Authors
O. L. Barbarash
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases;Federal State Budgetary Educational Institution of Higher Education Kemerovo State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Barbarash OlgaL., Ph.D., Professor, Corresponding Member of the Russian Academy of Sciences, Director Research Institute for Complex Issues of Cardiovascular Diseases; Chief, Division of Cardiology and Cardiovascular Surgery, Kemerovo State MU.
6, Sosnoviy Blvd., Kemerovo, 650002;22a, Voroshilova St., Kemerovo, 650070
Competing Interests:
входтит в редакционную коллегию журнала «Комплексные проблемы сердечно-сосудистых заболеваний»
V. V. Kashtalap
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases;Federal State Budgetary Educational Institution of Higher Education Kemerovo State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Kashtalap Vasily V., MD, Ph.D., Associate Professor, Head of the Department of Clinical Cardiology, Research Institute for Complex Issues of Cardiovascular Diseases, Professor, Division of Cardiology and Cardiovascular Surgery, Kemerovo State MU.
6, Sosnoviy Blvd., Kemerovo, 650002;22a, Voroshilova St., Kemerovo, 650070
Competing Interests:
входтит в редакционную коллегию журнала «Комплексные проблемы сердечно-сосудистых заболеваний»
A. A. Garganeeva
Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation
Competing Interests:
Russian Federation
Garganeeva Alla A., MD, Ph.D., Professor, Head of the Department of Myocardial Pathology, Cardiology Research Institute.
111a, Kievskaya St., Tomsk, 634012
Competing Interests:
входтит в редакционную коллегию журнала «Комплексные проблемы сердечно-сосудистых заболеваний»
K. V. Protasov
Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Protasov Konstantin V., Ph.D., Professor, Deputy Director of Scientific Development, Head of the Department of Cardiology and Functional Diagnostics.
100, mkr. Yubilejnyj, Irkutsk, Russian Federation, 664049
Competing Interests:
отсутствие конфликта интересов
O. Yu. Korennova
Omsk State Medical University
Russian Federation
Competing Interests:
Russian Federation
Korennova Olga Y., MD, Ph.D., Professor, Division of Internal Diseases and Family Medicine.
12, Lenina St., 644099
Competing Interests:
отсутствие конфликта интересов
N. G. Gogolashvili
Research Institute of Medical Problems of the North, Federal Research Center Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky
Russian Federation
Competing Interests:
Russian Federation
Gogolashvili Nikolai H., MD, Ph.D., Principal Researcher, Head of the Department of Cardiology.
50, Akademgorodok St., Krasnoyarsk, Russian Federation, 660036; 1, Partizana Zheleznyaka St., Krasnoyarsk, 660022
Competing Interests:
отсутствие конфликта интересов
A. S. Salasyuk
Federal State Government-Financed Educational Institution of Higher Education Volgograd State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Salasyuk Alla Sergeevna, Ph.D., Associate Professor, Department of Therapy and Endocrinology, Faculty of Advanced Medical Studies.
1, Pavshikh Bortsov Sq., Volgograd, 400131
Competing Interests:
отсутствие конфликта интересов
A. A. Efremushkina
Altai State Medical University
Russian Federation
Competing Interests:
Russian Federation
Efremushkina Anna A., MD, Ph.D., Professor, Division of Therapy and General Medical Practice.
40, Lenina Ave., Barnaul, 656038
Competing Interests:
отсутствие конфликта интересов
S. L. Zharskiy
Far-Eastern State Medical University
Russian Federation
Competing Interests:
Russian Federation
Zharskiy Sergey L., MD, Ph.D., Professor, Chief, Division of Faculty and Polyclinic Therapy.
35, Muravyov-Amursky St., Khabarovsk, 680000
Competing Interests:
отсутствие конфликта интересов
S. A. Zenin
Novosibirsk Regional Clinical Cardiological Dispensary
Russian Federation
Competing Interests:
Russian Federation
Zenin Sergey A., Ph.D., Chief Freelance Cardiologist of the Ministry of Health of the Novosibirsk Region.
Zalesskogo St., 6. Building 8, Novosibirsk, 630047
Competing Interests:
отсутствие конфликта интересов
S. А. Makarov
State Budgetary Healthcare Institution Kuzbass Clinical Cardiology Dispensary named after academician L.S. Barbarash
Russian Federation
Competing Interests:
Russian Federation
Makarov Sergey A., MD, Ph.D., Chief Cardiologist of the Kemerovo region, Chief Physician.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests:
входтит в редакционную коллегию журнала «Комплексные проблемы сердечно-сосудистых заболеваний»
V. A. Nevzorova
Federal State Budgetary Educational Institution of Higher Education Pacific State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Nevzorova Vera A., MD, PhD, Professor, Director of Institute of Therapy and Instrumental Diagnostic.
2, Ostryakova Ave., Vladivostok, 690002
Competing Interests:
отсутствие конфликта интересов
L. B. Sodnomova
State Autonomous Healthcare Institution Republican Clinical Hospital named after Nikolai Alexandrovich Semashko of the Ministry of Health of the Republic of Buryatia
Russian Federation
Competing Interests:
Russian Federation
Sodnomova Larisa B., Ph.D., cardiologist at the Department of Cardiology No. 1.
12 Pavlova St., Ulan-Ude, Republic of Buryatia, 670031
Competing Interests:
отсутствие конфликта интересов
S. A. Ustyugov
Regional Government-Owned Publicly Funded Healthcare Institution Regional Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Ustyugov Sergey A., MD, PhD, Associate Professor, Chief Cardiologist of the Krasnoyarsk region, Head of the Department of Cardiology No. 3.
3 a, Partizana Zheleznyaka St., Krasnoyarsk, 660022
Competing Interests:
отсутствие конфликта интересов
O. G. Tsygankova
State Budgetary Institution of Health Care Regional Clinical Hospital № 2
Russian Federation
Competing Interests:
Russian Federation
Tsygankova Olga G., Chief Endocrinologist of the Ministry of Health of Primorsky Krai, Head of the Department of Endocrinology No. 1.
55, Russkaya St., Vladivostok, 690105
Competing Interests:
отсутствие конфликта интересов
Yu. O. Shabelnikova
State Budgetary Healthcare Institution of the Novosibirsk Region State Novosibirsk Regional Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Shabelnikova Olesya Y, MD, PhD, Chief Endocrinologist of the Novosibirsk Region, Head of the Department of Endocrinology.
130, Nemirovicha-Danchenko St., Novosibirsk, 630087
Competing Interests:
отсутствие конфликта интересов
References
1. Koudstaal S., Pujades-Rodriguez M., Denaxas S., Gho admissions, or both: a population-based linked electronic health J.M.IH., Shah A.D., Yu N., Patel R.S., Gale C.P., Hoes A.W., record cohort study in 2.1 million people. Eur J Heart Fail. Cleland J.G., Asselbergs F.W., Hemingway H. Prognostic 2017;19(9):1119-1127. doi: 10.1002/ejhf.709. burden of heart failure recorded in primary care, acute hospital
2. Jones N.R., Roalfe A.K., Adoki I., Hobbs F.D.R., Taylor C.J. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21(11):1306-1325. doi: 10.1002/ejhf.1594.
3. Barbarash O.L., Kashtalap V.V. The Place of Pharmacoinvasive Management in Patients With ST-Elevation Acute Coronary Syndrome in Russia. Kardiologiia 2014; 9: 7985 (in Russian).
4. Kashtalap V.V, Zavyrylina I.N., Barbarash O.L. Endovascular revascularization for ST-elevation acute coronary syndrome in Russia: problems and prospects for the further development. Kreativnaya kardiologiya 2015; 3:5-15 (in Russian).
5. Barbarash O.L., Kashtalap V.V., Bykova I.S., Erlikh A.D., Gratsiansky N.A. on behalf of the workgroup of RECORD-3. Gender specifics of clinical course and in-patient stage of management in ST-elevation acute coronary syndrome patients (by the Russian Registry of Acute Coronary Syndrome «RECORD-3». Russ J Cardiol 2017, 6 (146): 122-131 (in Russian).
6. Zelniker T.A., Wiviott S.D., Raz I., Im K., Goodrich E.L., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Furtado R. H.M., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.PH., Sabatine M.S. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X.
7. Kato E.T., Silverman M.G., Mosenzon O., Zelniker T.A., Cahn A., Furtado R.H.M., Kuder J., Murphy S.A., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.P.H., Bonaca M.P., Ruff C.T., Desai A.S., Goto S., Johansson PA., Gause-Nilsson I., Johanson P., Langkilde A.M., Raz I., Sabatine M.S., Wiviott S. D. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. Circulation. 2019;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130.
8. Packer M. SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action. Diabetes Care. 2020;43(3):508-511. doi: 10.2337/dci19-0074.
9. McMurray J.J.V., DeMets D.L., Inzucchi S.E., K0ber L., Kosiborod M.N., Langkilde A.M., Martinez F.A., Bengtsson O., Ponikowski P, Sabatine M.S., Sjostrand M., Solomon S.D.; DAPA-HF Committees and Investigators. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail. 2019;21(5):665-675. doi: 10.1002/ejhf.1432.
10. Packer M., Anker S.D., Butler J., Filippatos G., Pocock S.J., Carson P., Januzzi J., Verma S., Tsutsui H., Brueckmann M., Jamal W., Kimura K., Schnee J., Zeller C., Cotton D., Bocchi E., Bohm M., Choi D.J., Chopra V, Chuquiure E., Giannetti N. , Janssens S., Zhang J., Gonzalez Juanatey J.R., Kaul S., Brunner-La Rocca H.P., Merkely B., Nicholls S.J., Perrone S., Pina I., Ponikowski P., Sattar N., Senni M., Seronde M.F., Spinar J., Squire I., Taddei S., Wanner C., Zannad F.; EMPeRoR-Reduced Trial Investigators. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi: 10.1056/NEJMoa2022190..
11. Barbarash O.L., Garganeeva A.A., Gogolashvili N.G., Efremushkina A.A., Zharskiy S.L., Kashtalap V.V, Korennova O. Yu., Makarov S.A., Nevzorova V.A., Protasov K.V., Ustyugov S.A., Shabelnikova O.Yu. The resolution on empagliflozin and heart failure has been adopted by the experts of the Siberian Federal District based on the results of the EMPEROR-Reduced study. Complex Issues of Cardiovascular Diseases. 2021;10(1):103-108. (In Russian).
Review
For citations:
Barbarash O.L., Kashtalap V.V., Garganeeva A.A., Protasov K.V., Korennova O.Yu., Gogolashvili N.G., Salasyuk A.S., Efremushkina A.A., Zharskiy S.L., Zenin S.A., Makarov S.А., Nevzorova V.A., Sodnomova L.B., Ustyugov S.A., Tsygankova O.G., Shabelnikova Yu.O. Resolution of an online meeting of the Siberian, Far Eastern and Southern Federal Districts experts on the results of the EMPEROR-Reduced trial “Therapeutic approaches in heart failure with reduced ejection fraction: the EMPA-REG OUTCOME trial and the EMPEROR-Reduced trial”. Complex Issues of Cardiovascular Diseases. 2021;10(3):121-129. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-3-121-129
Views:
429
